Names and pronunciation
(en′ta-kah-pone) Comtan
PDF page 472
Drug reference
(en′ta-kah-pone) Comtan
PDF page 472
Func. class.: Antiparkinson agent
PDF page 472
Chem. class.: COMT inhibitor
PDF page 472
USES: Parkinson’s disease for those experiencing end-of-dose, decreased effect as adjunct to levodopa/carbidopa
PDF page 473
CONTRAINDICATIONS: Hyper- sensitivity
PDF page 473
DOSAGE AND ROUTES • Adult: PO 200 mg given with carbi- dopa/levodopa, max 1600 mg/day; may allow for 25% dosage reduction in levodopa therapy
PDF page 473
Available forms: Tablets 200 mg
PDF page 473
• Adult: PO 200 mg given with carbi- dopa/levodopa, max 1600 mg/day; may allow for 25% dosage reduction in levodopa therapy
PDF page 473